About this trial
The aim of this study is to prove that Novosyn Quick and Monosyn Quick are equivalent in early wound healing in adult patients undergoing resective periodontal surgery.
In order to show equivalence between Novosyn Quick and Monosyn Quick EHS, which is composed of 3 parameters: clinical signs of reepithelization, clinical signs of haemostasis and clinical signs of inflammation, will be calculated for each suture 10 ± 5 days postoperatively and cannot differ more than 2 points.
Furthermore, complications, the handling of the suture material, pain, satisfaction of the patient and bacterial contamination of the thread (optional) will also be assessed as secondary objectives.
Eligibility criteria
Qualifiers
Crestal incision
Vertical incision
Intrasulcular incision
Submarginal incision
Disqualifiers
Emergency surgery.
Pregnancy.
Breastfeeding
Patients taking medication that might affect wound healing.
Trial design
Treatments tested in this trial
- Novosyn® in resective periodontal surgery
- Monosyn® in resective periodontal surgery
Treatment groups
Sponsors and collaborators
Aesculap AG
Lead sponsor
B.Braun Surgical SA
Collaborator